MARLBOROUGH, Mass.,
Aug. 24, 2016 /PRNewswire/ -- Boston
Scientific Corporation (NYSE: BSX) is scheduled to participate in
the Wells Fargo Healthcare Conference on September 7, in Boston.
Mike Mahoney, chief executive
officer, Dan Brennan, executive vice
president and chief financial officer, and Susie Lisa, vice president, Investor Relations,
will participate in a 30-minute question-and-answer-session with
the host analyst beginning at approximately 9:20 a.m. EDT.
A live webcast of the question-and-answer-session will be
available on the Investor Relations section of the Boston
Scientific website at www.bostonscientific.com/investors. We
encourage interested parties to register at least 15 minutes prior
to the scheduled start time to ensure a timely connection.
A replay of the webcast will be accessible at
www.bostonscientific.com/investors beginning approximately one hour
following the completion of the event.
About Boston Scientific
Boston Scientific transforms
lives through innovative medical solutions that improve the health
of patients around the world. As a global medical technology
leader for more than 35 years, we advance science for life by
providing a broad range of high performance solutions that address
unmet patient needs and reduce the cost of healthcare. For
more information, visit www.bostonscientific.com and connect on
Twitter and Facebook.
CONTACTS
|
Media:
|
Investors:
|
Tom
Keppeler
|
Susie Lisa,
CFA
|
508-683-6585
(office)
|
508- 683-5565
(office)
|
Media
Relations
|
Investor
Relations
|
Boston Scientific
Corporation
|
Boston Scientific
Corporation
|
thomas.keppeler@bsci.com
|
investor_relations@bsci.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-wells-fargo-2016-healthcare-conference-300315889.html
SOURCE Boston Scientific Corporation